{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:38:53Z","timestamp":1792539533137,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":3520,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s13311-013-0240-3","type":"journal-article","created":{"date-parts":[[2013,12,19]],"date-time":"2013-12-19T10:50:34Z","timestamp":1387450234000},"page":"208-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Treatment of Movement Disorder Emergencies"],"prefix":"10.1016","volume":"11","author":[{"given":"Steven J.","family":"Frucht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 4","key":"10.1007\/s13311-013-0240-3_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00415-008-4002-9","article-title":"Movement disorder emergencies","volume":"255","author":"Poston","year":"2008","journal-title":"J Neurol"},{"key":"10.1007\/s13311-013-0240-3_bib2","series-title":"Movement disorder emergencies, diagnosis and treatment, 2nd ed","year":"2013"},{"key":"10.1007\/s13311-013-0240-3_bib3","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.52.7.1467","article-title":"Acute and reversible parkinsonism due to organophosphate pesticide intoxication: five cases","volume":"52","author":"Bhatt","year":"1999","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0240-3_bib4","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/jnnp.44.8.670","article-title":"Post-encephalitic parkinsonism: current experience","volume":"44","author":"Rail","year":"1981","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-013-0240-3_bib5","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1212\/WNL.53.8.1781","article-title":"Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis","volume":"53","author":"Ogata","year":"1999","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0240-3_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0887-8994(91)90031-F","article-title":"Acute parkinsonian syndrome with demyelinating leukoencephalopathy in bone marrow transplant recipients","volume":"7","author":"Lockman","year":"1991","journal-title":"Pediatr Neurol"},{"key":"10.1007\/s13311-013-0240-3_bib7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/mds.10344","article-title":"Chemotherapy-induced parkinsonism responsive to levodopa: an under-recognized entity","volume":"18","author":"Chuang","year":"2003","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0240-3_bib8","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/mds.870100528","article-title":"Temporary worsening of parkinsonism in a patient with Parkinson's disease after treatment with paclitaxel for a metastatic grade IV adenocarcinoma","volume":"10","author":"Bower","year":"1995","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0240-3_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/mds.870010108","article-title":"Parkinsonism and acquired hydrocephalus","volume":"1","author":"Jankovic","year":"1986","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0240-3_bib10","series-title":"Awakenings","author":"Sacks","year":"1990"},{"key":"10.1007\/s13311-013-0240-3_bib11","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1001\/jama.1985.03360190098033","article-title":"A Neuroleptic malignant-like syndrome due to levodopa therapy withdrawal","volume":"15","author":"Friedman","year":"1985","journal-title":"JAMA"},{"key":"10.1007\/s13311-013-0240-3_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1055\/s-2008-1041226","article-title":"Neuroleptic malignant syndrome or parkinsonism hyperpyrexia syndrome","volume":"11","author":"Granner","year":"1991","journal-title":"Semin Neurol"},{"key":"10.1007\/s13311-013-0240-3_bib13","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1212\/WNL.43.5.1048","article-title":"Neuroleptic malignant syndrome in a parkinsonian woman during the premenstrual period","volume":"43","author":"Mizuta","year":"1993","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0240-3_bib14","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/mds.23596","article-title":"Case report: recurrent parkinsonism-hyperpyrexia syndrome following discontinuation of subthalamic deep brain stimulation","volume":"26","author":"Kadowaki","year":"2011","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0240-3_bib15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000113484","article-title":"Neuroleptic malignant syndrome in parkinsonian patients: risk factors","volume":"38","author":"Kuno","year":"1997","journal-title":"Eur Neurol"},{"key":"10.1007\/s13311-013-0240-3_bib16","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/jnnp.74.5.574","article-title":"Efficacy of methylprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease","volume":"74","author":"Sato","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-013-0240-3_bib17","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.4088\/JCP.10m06438","article-title":"An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method","volume":"72","author":"Gurrera","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"10.1007\/s13311-013-0240-3_bib18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/mds.870050215","article-title":"Neuroleptic malignant syndrome treated with subcutaneous lisuride infusion","volume":"5","author":"Rodriguez","year":"1990","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0240-3_bib19","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/mds.1133","article-title":"Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy","volume":"16","author":"Wang","year":"2001","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0240-3_bib20","first-page":"102","article-title":"ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome","volume":"48","author":"Addonizio","year":"1987","journal-title":"J Clin Psych"},{"key":"10.1007\/s13311-013-0240-3_bib21","series-title":"Movement disorder emergencies: Diagnosis and treatment","first-page":"75","article-title":"Psychosis and Parkinson's disease","author":"Vaughan","year":"2013"},{"key":"10.1007\/s13311-013-0240-3_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/000348948309200121","article-title":"Vocal fold paresis in Shy-Drager syndrome","volume":"92","author":"Hanson","year":"1983","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1007\/s13311-013-0240-3_bib23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/1531-8257(200007)15:4<699::AID-MDS1015>3.0.CO;2-L","article-title":"Stridor and death in multiple system atrophy","volume":"15","author":"Silber","year":"2000","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0240-3_bib24","first-page":"213","article-title":"Morphometric study of nucleus ambiguous in multiple system atrophy presenting with vocal cord abductor paralysis","volume":"19","author":"Isozaki","year":"2000","journal-title":"Clin Neuropathol"},{"key":"10.1007\/s13311-013-0240-3_bib25","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/BF00873518","article-title":"Laryngeal electromyography with separated surface electrodes in patients with multiple system atrophy presenting with vocal cord paralysis","volume":"241","author":"Isozaki","year":"1994","journal-title":"J Neurol"},{"key":"10.1007\/s13311-013-0240-3_bib26","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(00)02824-5","article-title":"Continuous positive air pressure eliminates nocturnal stridor in multiple system atrophy","volume":"356","author":"Iranzo","year":"2000","journal-title":"Lancet"},{"key":"10.1007\/s13311-013-0240-3_bib27","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s001060170080","article-title":"Botulinum toxin type A-induced \u201crebalancing\u201d in bilateral vocal cord paralysis?","volume":"49","author":"Ptok","year":"2001","journal-title":"HNO"},{"key":"10.1007\/s13311-013-0240-3_bib28","first-page":"235","article-title":"Partial posterior cordectomy with laser CO2 in bilateral recurrent paralysis","volume":"109","author":"Merite","year":"1992","journal-title":"Ann Otolaryngol Chir Cervicofac"},{"key":"10.1007\/s13311-013-0240-3_bib29","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1212\/WNL.32.10.1195","article-title":"Severe dystonia and myoglobinuria","volume":"32","author":"Jankovic","year":"1982","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0240-3_bib30","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/brain\/121.2.243","article-title":"Status dystonicus: the syndrome and its management","volume":"121","author":"Manji","year":"1998","journal-title":"Brain"},{"key":"10.1007\/s13311-013-0240-3_bib31","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/mds.870130344","article-title":"Intrathecal baclofen in the treatment of dystonic storm","volume":"13","author":"Dalvi","year":"1998","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0240-3_bib32","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/mds.23586","article-title":"Treatment of a dystonic storm with pallidal stimulation in a patient with PANK2 mutation","volume":"26","author":"Grandas","year":"2011","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0240-3_bib33","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0033-3182(89)72240-4","article-title":"Acute laryngeal dystonic reactions to neuroleptics","volume":"30","author":"Koek","year":"1989","journal-title":"Psychosomatics"},{"key":"10.1007\/s13311-013-0240-3_bib34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0140-6736(70)92572-9","article-title":"L-dopa and oculogyric crises","volume":"2","author":"Sacks","year":"1970","journal-title":"Lancet"},{"key":"10.1007\/s13311-013-0240-3_bib35","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1161\/01.STR.0000022810.76115.C0","article-title":"Long-term prognosis of vascular hemiballismus","volume":"33","author":"Ristic","year":"2002","journal-title":"Stroke"},{"key":"10.1007\/s13311-013-0240-3_bib36","series-title":"Movement disorder emergencies: Diagnosis and treatment","first-page":"151","article-title":"Hemballism-hemichorea","author":"Postuma","year":"2013"},{"key":"10.1007\/s13311-013-0240-3_bib37","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1002\/mds.21100","article-title":"Tetrabenazine for hyperglycemic-induced hemichorea-hemiballismus","volume":"21","author":"Sitburana","year":"2006","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0240-3_bib38","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/1531-8257(199905)14:3<497::AID-MDS1019>3.0.CO;2-X","article-title":"Hemichorea and hemiballism associated with contralateral hemiparesis and ipsilateral basal ganglia lesions","volume":"14","author":"Krauss","year":"1999","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0240-3_bib39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejpn.2011.12.005","article-title":"Acute and chronic corticosteroid treatment of ten patients with paralytic form of Sydenham's chorea","volume":"16","author":"Fusco","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1007\/s13311-013-0240-3_bib40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0883073811414058","article-title":"Treatment of Sydenham chorea with intravenous immunoglobulin","volume":"27","author":"Walker","year":"2012","journal-title":"J Child Neurol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-013-0240-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-013-0240-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923016513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923016513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-013-0240-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:07:30Z","timestamp":1761808050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923016513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1878747923016513"],"URL":"https:\/\/doi.org\/10.1007\/s13311-013-0240-3","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Movement Disorder Emergencies","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-013-0240-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}